111 related articles for article (PubMed ID: 1469957)
1. Bioavailability/bioequivalence of modified release drug delivery systems: which pharmacokinetic parameters to determine, single or multiple dose studies, pretests, conditions and other aspects.
Ritschel WA
Methods Find Exp Clin Pharmacol; 1992; 14(6):469-82. PubMed ID: 1469957
[No Abstract] [Full Text] [Related]
2. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability and bioequivalence trials: statistics & pharmacokinetic principles.
Rajaram L; Roy SK; Skerjanec A
Stud Health Technol Inform; 2004; 103():159-79. PubMed ID: 15747918
[TBL] [Abstract][Full Text] [Related]
4. Alternative approach to relative bioavailability and bioequivalence evaluation, with drugs following Michaelis-Menten elimination kinetics.
Fagiolino P; Stareczek S
Farmaco; 1990 Sep; 45(9):1027-36. PubMed ID: 2282123
[TBL] [Abstract][Full Text] [Related]
5. [The bioequivalence of two nifedipine sustained-release formulations after single administration in steady state].
Meyer FP; Banditt P
Arzneimittelforschung; 1993 Jun; 43(6):646-50. PubMed ID: 8352817
[TBL] [Abstract][Full Text] [Related]
6. Considerations for metabolite pharmacokinetic data in bioavailability/bioequivalence assessments. Overview of the recent trends.
Srinivas NR
Arzneimittelforschung; 2009; 59(4):155-65. PubMed ID: 19517891
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalence of venlafaxine modified-release capsule revisited with an innovative approach using experimental and predictive models.
Goswami D; Khuroo AH; Gurule S; Kumar A; Monif T
Bioanalysis; 2011 Jan; 3(1):31-43. PubMed ID: 21175365
[TBL] [Abstract][Full Text] [Related]
8. [Bioequivalence of enteric coated tablet of Zhengqing Fengtongning].
Zhang SH; Zhou YD; He HX
Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(6):683-5. PubMed ID: 18590201
[TBL] [Abstract][Full Text] [Related]
9. Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration.
Dulac O; Alvarez JC
Pharmacotherapy; 2005 Jan; 25(1):35-41. PubMed ID: 15767218
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence studies: single vs multiple dose.
Steinijans VW; Sauter R; Jonkman JH; Schulz HU; Stricker H; Blume H
Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S31-6. PubMed ID: 1601529
[TBL] [Abstract][Full Text] [Related]
11. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.
Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B
Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082
[TBL] [Abstract][Full Text] [Related]
12. Bioequivalence studies: single vs multiple dose.
Steinijans VW; Sauter R; Jonkman JH; Schulz HU; Stricker H; Blume H
Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):261-6. PubMed ID: 2737794
[TBL] [Abstract][Full Text] [Related]
13. [Clinical pharmacokinetics of allopurinol. 3. Allopurinol/oxipurinol pharmacokinetics following administration of a controlled release allopurinol preparation].
Gikalov I; Radivojevich F; Schiemann O; Fenner H
Arzneimittelforschung; 1986 Jun; 36(6):988-93. PubMed ID: 3741536
[TBL] [Abstract][Full Text] [Related]
14. Effect of doses on the bioavailability of phenytoin from a prompt-release and an extended-release preparation: single dose study.
Rojanasthien N; Chaichana N; Teekachunhatean S; Kumsorn B; Sangdee C; Chankrachang S
J Med Assoc Thai; 2007 Sep; 90(9):1883-93. PubMed ID: 17957935
[TBL] [Abstract][Full Text] [Related]
15. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
González MA; Straughan AB
Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
[TBL] [Abstract][Full Text] [Related]
16. Comparing the concentration curves directly in a pharmacokinetics, bioavailability/bioequivalence study.
Liao JJ
Stat Med; 2005 Mar; 24(6):883-91. PubMed ID: 15558699
[TBL] [Abstract][Full Text] [Related]
17. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects.
Marier JF; Ducharme MP; DiMarco M; Di Spirito M; Morelli G; Tippabhotla SK; Badri N; Rampal A; Monif T
Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence and relative bioavailability of a new diltiazem sustained release formulation.
Scheiwe MW; Lankhaar G; Kleinbloesem CH
Arzneimittelforschung; 1996 Oct; 46(10):960-3. PubMed ID: 8931888
[TBL] [Abstract][Full Text] [Related]
19. [Bioavailability of theophylline in a new oral sustained-release preparation (author's transl)].
Schneider GF; Heese GU; Huber HJ; Janzen N; Jünger H; Moser C; Stanislaus F
Arzneimittelforschung; 1981; 31(9):1489-97. PubMed ID: 7197962
[TBL] [Abstract][Full Text] [Related]
20. [Modulation of in vivo fate of drugs: fundamental biopharmaceutical and pharmacokinetic aspects].
Devissaguet JP
Ann Pharm Fr; 2001 Jul; 59(4):219-26. PubMed ID: 11468575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
